Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralair in adult grass pollen rhinoconjunctivitis
NCT00955825Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of Oralair in allergic rhinoconjunctivitis (ARC), sponsored by Stallergenes Greer. Started Oct 2008; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00955825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955825.